Jeffery M. Vahrenkamp

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition

Gürkan Mollaoglu, Matthew R. Guthrie, Stefanie Böhm et al. · Cancer Cell · 2017 · 570 citations · Full text

Variant Neuroendocrine Subtype, Aurora Kinase Inhibition, Oncogenic Agent +9

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

Katrin P. Guillen, Maihi Fujita, Andrew Butterfield et al. · Nature Cancer · 2022 · 365 citations · Full text

The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment

Gürkan Mollaoglu, Alex Jones, Sarah J. Wait et al. · Immunity · 2018 · 205 citations · Full text

Tumor Immune Microenvironment, Cancer Immunosurveillance, Medicine +7

MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion

Milind D. Chalishazar, Sarah J. Wait, Fang Huang et al. · Clinical Cancer Research · 2019 · 173 citations

Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer

Jeffery M. Vahrenkamp, Chieh-Hsiang Yang, Adriana C. Rodriguez et al. · Cell Reports · 2018 · 75 citations · Full text